Raymond James & Associates CANTEL MED CORP Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 14, 2021	SELL	N/A	-8,046 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	N/A	2,780 Added 52.79%	8,046 $635,000
Q3 2020 Nov 04, 2020	BUY	N/A	5,266 New	5,266 $231,000
Q2 2020 Jul 28, 2020	SELL	N/A	-46,005 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	N/A	13,230 Added 40.37%	46,005 $1.65 Million
Q4 2019 Feb 12, 2020	BUY	N/A	24,217 Added 282.97%	32,775 $2.32 Million
Q3 2019 Nov 07, 2019	BUY	N/A	4,707 Added 122.23%	8,558 $640,000
Q2 2019 Aug 06, 2019	BUY	N/A	486 Added 14.44%	3,851 $311,000
Q1 2019 May 06, 2019	BUY	N/A	228 Added 7.27%	3,365 $225,000
Q4 2018 Feb 11, 2019	SELL	N/A	-487 Reduced 13.44%	3,137 $234,000
Q3 2018 Nov 14, 2018	SELL	N/A	-1,006 Reduced 21.73%	3,624 $334,000
Q2 2018 Aug 14, 2018	BUY	N/A	1,192 Added 34.67%	4,630 $455,000
Q1 2018 May 14, 2018	BUY	N/A	466 Added 15.68%	3,438 $383,000
Q4 2017 Feb 14, 2018	BUY	N/A	381 Added 14.7%	2,972 $306,000
Q3 2017 Nov 13, 2017	BUY	N/A	2,591	2,591 $244,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.